Eurofins Scientific (ESF0) Stock Forecast & Price Target

5 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ESF0 Analyst Ratings

Hold

1 Buy

1 Hold

1 Sell

Based on 3 analysts giving stock ratings to

Eurofins

Scientific

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ESF0 Stock 12 Month Forecast

Average Price Target

€70.83

▲(0.64% Upside)

Based on 3 Wall Street analysts offering 12 month price targets for Eurofins Scientific in the last 3 months. The average price target is €70.83 with a high forecast of €86.00 and a low forecast of €58.00. The average price target represents a 0.64% change from the last price of €70.38.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"56":"€56","87":"€87","63.75":"€63.8","71.5":"€71.5","79.25":"€79.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":86,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€86.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":70.83333333333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€70.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":58,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€58.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[56,63.75,71.5,79.25,87],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.36,69.71692307692308,71.07384615384615,72.43076923076923,73.78769230769231,75.14461538461538,76.50153846153846,77.85846153846154,79.21538461538461,80.57230769230769,81.92923076923077,83.28615384615384,84.64307692307692,{"y":86,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.36,68.55025641025641,68.74051282051282,68.93076923076923,69.12102564102564,69.31128205128205,69.50153846153846,69.69179487179487,69.88205128205128,70.07230769230769,70.2625641025641,70.45282051282051,70.64307692307692,{"y":70.83333333333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.36,67.56307692307692,66.76615384615384,65.96923076923076,65.1723076923077,64.37538461538462,63.57846153846154,62.78153846153846,61.98461538461538,61.18769230769231,60.39076923076923,59.59384615384616,58.79692307692308,{"y":58,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":59.89,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.314,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.902,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.408,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.325,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.38,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.629,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.59,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.571,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.199,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.38,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.02,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.36,"date":1782864000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€86.00

Average Price Target€70.83

Lowest Price Target€58.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Allen Wells

Jefferies

€60→€58

Sell

-17.59%

Downside

Reiterated

07/29/26

Jefferies Remains a Sell on Eurofins Scientific (0MV5)

Remi Grenu

Morgan Stanley

€67.5→€68.5

Hold

-2.67%

Downside

Reiterated

07/28/26

Eurofins Scientific price target raised to EUR 68.50 at Morgan StanleyEurofins Scientific price target raised to EUR 68.50 at Morgan Stanley

Francois Digard

Kepler Capital

€81→€86

Buy

22.19%

Upside

Reiterated

05/18/26

Kepler Capital Keeps Their Buy Rating on Eurofins Scientific (0MV5)

Arthur Truslove

Citi

€63.5→€73.7

Hold

4.72%

Upside

Reiterated

02/02/26

Eurofins Scientific price target raised to EUR 73.70 from EUR 63.50 at CitiEurofins Scientific price target raised to EUR 73.70 from EUR 63.50 at Citi

Tom Burlton

Exane BNP Paribas

€51.5→€75

Buy

6.56%

Upside

Upgraded

01/05/26

Eurofins Scientific upgraded to Outperform from Underperform at BNP ParibasEurofins Scientific upgraded to Outperform from Underperform at BNP Paribas

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Allen Wells

Jefferies

€60→€58

Sell

-17.59%

Downside

Reiterated

07/29/26

Jefferies Remains a Sell on Eurofins Scientific (0MV5)

Remi Grenu

Morgan Stanley

€67.5→€68.5

Hold

-2.67%

Downside

Reiterated

07/28/26

Eurofins Scientific price target raised to EUR 68.50 at Morgan StanleyEurofins Scientific price target raised to EUR 68.50 at Morgan Stanley

Francois Digard

Kepler Capital

€81→€86

Buy

22.19%

Upside

Reiterated

05/18/26

Kepler Capital Keeps Their Buy Rating on Eurofins Scientific (0MV5)

Arthur Truslove

Citi

€63.5→€73.7

Hold

4.72%

Upside

Reiterated

02/02/26

Eurofins Scientific price target raised to EUR 73.70 from EUR 63.50 at CitiEurofins Scientific price target raised to EUR 73.70 from EUR 63.50 at Citi

Tom Burlton

Exane BNP Paribas

€51.5→€75

Buy

6.56%

Upside

Upgraded

01/05/26

Eurofins Scientific upgraded to Outperform from Underperform at BNP ParibasEurofins Scientific upgraded to Outperform from Underperform at BNP Paribas

Stocks with the Highest Top Analyst Consensus in the General Sector

ITGITG Inc. Class A

LIMENeutron Holdings, Inc.

EROCERock

CBRSCerebras Systems, Inc. Class A

FRVOFervo Energy Company Class A

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Eurofins Scientific

3 Months

Tom BurltonExane BNP Paribas

Success Rate

15/18 ratings generated profit

Average Return

+13.56%

Copying Tom Burlton's trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +13.56% per trade.

1 Year

Tom BurltonExane BNP Paribas

Success Rate

17/18 ratings generated profit

Average Return

+41.00%

Copying Tom Burlton's trades and holding each position for 1 Year would result in 94.44% of your transactions generating a profit, with an average return of +41.00% per trade.

2 Years

Tom BurltonExane BNP Paribas

Success Rate

17/18 ratings generated profit

Average Return

+91.35%

Copying Tom Burlton's trades and holding each position for 2 Years would result in 94.44% of your transactions generating a profit, with an average return of +91.35% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ESF0 Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ESF0 has received 1 Buy Ratings, 1 Hold Ratings, and 2 Sell Ratings. ESF0 average Analyst price target in the past 3 months is 70.83.

Each month's total comprises the sum of three months' worth of ratings.

ESF0 Financial Forecast

ESF0 Earnings Forecast

Next quarter’s earnings estimate for ESF0 is €1.62 with a range of €1.62 to €1.62. The previous quarter’s EPS was €2.09. ESF0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 51.03% of the time in the same period. In the last calendar year ESF0 has Performed in-line its overall industry.

ESF0 Sales Forecast

Next quarter’s sales forecast for ESF0 is €3.81B with a range of €3.81B to €3.81B. The previous quarter’s sales results were €3.70B. ESF0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.11% of the time in the same period. In the last calendar year ESF0 has Performed in-line its overall industry.

ESF0 Stock Forecast FAQ

What is DE:ESF0’s average 12-month price target, according to analysts?

Based on analyst ratings, Eurofins Scientific’s 12-month average price target is 70.83.

What is DE:ESF0’s upside potential, based on the analysts’ average price target?

Eurofins Scientific has 0.64% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Eurofins Scientific a Buy, Sell or Hold?

Eurofins Scientific has a consensus rating of Hold, which is based on 1 buy ratings, 1 hold ratings and 1 sell ratings.

What is Eurofins Scientific’s share price target?

The average share price target for Eurofins Scientific is 70.83. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €86.00 ,and the lowest forecast is €58.00. The average share price target represents 0.64% Increase from the current price of €70.38.

What do analysts say about Eurofins Scientific?

Eurofins Scientific’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Streets Analysts.

How can I buy shares of Eurofins Scientific?

To buy shares of DE:ESF0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Eurofins Scientific (ESF0) Stock Forecast & Price Target

ESF0 Analyst Ratings

ESF0 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Eurofins Scientific

ESF0 Analyst Recommendation Trends

ESF0 Financial Forecast

ESF0 Earnings Forecast

ESF0 Sales Forecast

ESF0 Stock Forecast FAQ

Detailed List of Analyst Forecasts